Credits: Canva
Spring is around the corner, it means warmer weather, flowers blooming, but also pollen, allergy, lots of sneezing, wheezing and itchy eyes. If you are someone who rarely enjoys this season, and spends most of it battling congestion and brain fog, then this is for you! Learn how to manage your spring allergies.
Spring allergies can be treated with simple lifestyle changes, and if at all it is required, even advanced medical interventions too can take care of it. Here are some tips that the American College of Allergy, Asthma & Immunology (ACAAI) recommends:
Before turning to medications, try considering these lifestyle changes and see if it works:
1. Shut Your Windows: Pollen counts are usually at the highest in early morning and evening. This is the time when you can start keeping your windows and doors closed. Whether you are at your home or in your car, this way you can prevent pollen from entering. You can also use air conditioning instead of opening the windows and keep the indoor cool.
2. Bed-Time Routine: If you have spent your day outdoors, the best thing to do is to take a shower and change your clothes before you hit the bed. This is a great way to get rid of pollen from your clothes, skin, and hair. This will reduce your chance of sleeping om a pillow full of pollen
3. Air Purifiers: You can use HEPA, also known as the High-efficiency particulate air filters, which can catch pollen, pet dander and dust and other kinds of air purifier to filter out allergens.
4. Limit Outdoor Activities: Try to limit your activities especially early in the morning and in the evening. If you must go, put on a mask. An N-95 mask, which had peaked during COVID-19 times could come handy even now.
5. Spring Cleaning: Clean your house, and other surfaces. Even if you do not see the dust, it is there, and cleaning those surfaces will help you get rid of accumulation of pollen and other allergens.
In case these lifestyle changes are not helping you, you can go for over-the-counter medications. These include:
1. Antihistamines: They block histamine, which is a chemical released in body during an allergic reaction. It also reduces symptoms like sneezing, runny nose and itchy eyes.
2. Nasal Sprays: These could be your best friend if you are struggling with congestion. You can also use saline nasal sprays and neti pots.
3. Decongestants: These help by narrowing blood vessels in the nasal passages, and reduce swelling, which in return improves airflow.
Note that we do not recommend or prescribe any medicines. It is always advisable to go see your GP first.
Your doctor is most likely to prescribe a desloratadine in case your symptoms are not controlled with OTC medications. You may also be prescribed azelastine that could work better on your inflammation and congestion.
If you have severe allergy symptoms, you may be put on corticosteroids for short-term oral use. It can reduce inflammation throughout the body.
This is called allergy immunotherapy, which is a long-term solution that can desensitize your immune system to specific allergens. This treatment is considered when other treatments are ineffective and when allergies significantly impact your daily life.
The two allergy immunotherapy involves, a shot called subcutaneous immunotherapy or SCIT, and sublingual immunotherapy or SPLI, which is an allergen tablets placed under the tongue.
Credit: iStock
Nicotine pouches have become popular in the UK, show many studies, this is especially true in the case of young adults.
In fact, a new study done by the researches from University College London (UCL) has found that in the last five years, there has been an increase from 0.1 per cent to 1 per cent of adults using nicotine pouches. This means, around 522,000 more people in the UK have started using the pouches.
The pouches are placed between the lip and gum and it releases nicotine slowly. The pouches are also available in variety of flavors, with sweeteners and plant-based fibers. It does not contain tobacco like vapes do and usually are considered to be a healthier alternative to smoking.
Health and Me ran a fact check on whether it truly is safer than smoking, and here is what we found.
Are Nicotine Pouches Safer Than Smoking?
"This risks are substantially less than some other nicotine products like smoking, because there is no tobacco and there is no combustion," said Dr Harry Tattan-Birch, the lead author of the study, to Mornings with Ridge and Frost.
"And we know the combustion of tobacco is the thing that causes most of the diseases related to smoking," he says.
However, he and his team has warned that while it may not cause serious illness like tobacco can, young people could have a negative impact in their lungs and brains, as they are still in developing stage. This makes them more sensitive to the effects of nicotine, and it could become difficult to stop using it.
A UCL research fellow earlier told Sky News that while nicotine pouches are far less harmful than smoking, their long-term effects remain unclear because they are relatively new. Drawing on what is known about their contents, she noted they are not risk-free, as users are still exposed to some toxic substances, albeit at much lower levels.
Who Are Using These Nicotine Pouches?
Researchers from UCL, supported by Cancer Research UK, analysed survey responses from 127,793 people aged 16 and above across England, Scotland and Wales, collected between October 2020 and March 2025.
Their analysis showed that nicotine pouch use among 16 to 24-year-olds rose to 4% in 2025, up from just 0.7% in 2022. The increase was most pronounced among young men, with one in 13 men in this age group, or 7.5%, reporting use.
Overall, men accounted for 72% of nicotine pouch users between 2022 and 2025, while 47% were under the age of 25. Dr Tattan-Birch said the growth in use has been driven almost entirely by young people, particularly young men, with usage among adults over 35 remaining low and largely unchanged.
He added that this trend also includes children. Since nicotine pouches are not classified as tobacco or vape products, there are currently no age limits. Advertising is also unrestricted, allowing brightly coloured, sweet-flavoured products to appeal to younger audiences.
Do Nicotine Pouches Help Quit Smoking?
The research found that 69 per cent of pouch users were reported using other nicotine products, while 56 per cent of them smoked, as per the survey from January 2022 to March 2025.
1 in 6, which makes it 16 per cent said they never regularly smoked. "Whether nicotine pouches are good or bad for public health depends on who is using them. If it's a young person who would otherwise start smoking, then the use of pouches might help to reduce harm. However, if it's a person who otherwise would not use nicotine at all, then the potential for harm increases," said Tattan-Birch.
Credits: canva
A woman experiencing abdominal discomfort went to her gynecologist for an ultrasound, only to discover something far more startling than a baby. The mom, who shares her story on TikTok under the handle @sandwitchbread, revealed her medical surprise in a video that has now amassed over 1.9 million views. She said she had been struggling with pain and unusual bleeding since giving birth to her two-year-old son and decided to see a gynecologist fearing she might be pregnant again.
During the ultrasound, she noticed something on the screen, but the doctor quickly reassured her it wasn’t a baby. “When my doctor came in to share the results,” the TikToker recalled, “she looked me in the eyes and told me I had a seven-centimeter cyst, about the size of a chicken egg, called a dermoid cyst.”
A dermoid cyst is a pocket of tissue growth that can contain normal body tissues, sometimes including hair, fluid, teeth, or skin. While this TikToker’s cyst was in her uterus, dermoid cysts are most commonly found in the ovaries. They are generally harmless but often require surgical removal. According to the National Cancer Institute, dermoid cysts are present from birth but may not be detected until later in life. These benign tumors originate from embryonic cells that become “trapped” and develop into tissues in the wrong location. Teeth and hair are frequent components, and surgery is usually recommended if the cyst causes symptoms or complications.
Dermoid cysts develop hair and teeth because they arise from trapped embryonic cells (ectoderm) that can grow into skin, hair follicles, sweat glands, and even teeth, instead of forming the tissues normally found in the ovary or skin. Essentially, they are benign tumors made up of mature but misplaced body tissues from the outer layer of the embryo, which normally forms skin and related structures.
Most ovarian dermoid cysts remain symptom-free unless complications occur. When symptoms do appear, the most common one reported is lower abdominal pain.
As the cyst enlarges, it can cause noticeable abdominal swelling and problems with the urinary or digestive system.
In more severe cases, individuals might also experience:
The Office on Women’s Health notes that cysts on the ovaries can also cause:
Some potential complications include:
Rupturing of the cyst: Though rare, ovarian dermoid cysts can burst. If the cyst’s contents leak into the abdominal cavity, it may lead to chronic inflammation of the abdominal lining (peritonitis). In some cases, leakage into the intestines or rectum can result in the material being expelled through the anus.
Ovarian torsion: This occurs when the cyst twists the ligaments holding the ovary in place, which can cut off blood supply to the ovary and fallopian tube.
Infection: The risk of infection is around 1–4%. Severe infections may lead to cyst rupture.
Malignant transformation: Dermoid cysts are almost always benign, but in rare instances, they can become cancerous.
Credits: Canva
A new weight-loss drug often described as the “triple G” treatment because it mimics three hormones linked to hunger and metabolism has delivered striking results in fresh data shared Thursday by its developer, Eli Lilly. In a clinical study involving more than 400 people living with obesity and knee osteoarthritis, the experimental drug retatrutide led to an average weight reduction of 71 pounds, or close to 29% of total body weight, over a period of 16 months, according to figures released by the company. Participants who received retatrutide also reported a 76% drop in knee pain by the end of the study period, based on the same data. So is
Retatrutide is an experimental weight-loss drug developed by Eli Lilly and is widely seen as a next-step advancement beyond current GLP-1-based medications such as semaglutide and tirzepatide. While semaglutide acts on a single hormone pathway and tirzepatide works on two, retatrutide targets three.
It activates GLP-1 and GIP, along with an added glucagon pathway, which is why it is sometimes informally referred to as a “GLP-3” drug. Researchers believe this third pathway could explain the greater weight-loss effects seen so far, although retatrutide remains under investigation and has not yet received FDA approval.
Even without regulatory approval, retatrutide has gained attention among gym enthusiasts, fitness creators, and online weight-loss communities. On platforms like TikTok, where direct searches for #reta or #retatrutide are restricted, users often refer to it using coded terms such as “ratatouille.”
At the same time, the drug has been in the news due to growing concerns about counterfeit versions. Reports from the UK recently revealed that authorities seized more than £250,000 worth of fake weight-loss injection pens labelled as tirzepatide and retatrutide from a hidden factory in Northampton. These products are especially concerning because retatrutide is still in clinical trials and has not been approved for use anywhere in the world.
Retatrutide works by mimicking three hormones that play a role in appetite and metabolism: GLP-1, GIP, and glucagon. In contrast, most weight-loss drugs currently available target only one or two of these pathways. Ozempic and Wegovy, made by Novo Nordisk, copy the effects of GLP-1, a hormone that influences the brain, pancreas, stomach, liver, and muscles, according to the National Institutes of Health.
Mounjaro and Zepbound, on the other hand, act on both GLP-1 and GIP, a hormone involved in blood sugar regulation through insulin stimulation. Retatrutide’s added glucagon effect is key, as glucagon is known to support fat burning, even when the body is at rest. Ozempic and Mounjaro are approved by the FDA for treating Type 2 diabetes, while Wegovy and Zepbound are approved for people with overweight or obesity. As with any prescription drug, it is important for individuals to consult a healthcare professional to determine whether these treatments are appropriate for them.
There is currently no confirmed timeline for when retatrutide might become available by prescription. Its launch will depend on the FDA’s detailed evaluation of clinical trial data once it is formally submitted. Based on current expectations, approval is unlikely before late 2026 and could potentially extend into 2027 or even 2028.
© 2024 Bennett, Coleman & Company Limited